Oxytocin Dosage Calculator
Oxytocin is a nine-amino-acid neuropeptide produced in the hypothalamus and released by the posterior pituitary.
12mcg · Daily
Summary: Add 2mL BAC water to your 1mg vial. Draw to 2.4 units on a U-100 syringe for a 12mcg dose. This vial will last 83 doses.
Cycle Planner
Oxytocin Pharmacokinetics
Pharmacokinetics — Active Dose Over Time
t½ = ~3 min (IV), central effects last 2-4 hours (intranasal)Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Oxytocin Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 12 IU | Daily |
| Moderate | 24 IU | Daily |
| Aggressive | 48 IU | Daily |
Note: Dosing in IU: 1 IU ≈ 1.68 mcg. Beginner = ~12 IU, moderate = ~24 IU, aggressive = ~48 IU. Intranasal preferred for behavioral effects. FDA-approved as Pitocin (IV) for labor only — all psychiatric and social applications are off-label. Cycle: 4 weeks on, 4 weeks off.
About Oxytocin
Oxytocin is a nine-amino-acid neuropeptide produced in the hypothalamus and released by the posterior pituitary. It's best known for its role in labor and breastfeeding, but research over the past two decades has revealed a much broader profile. Intranasal oxytocin has been studied extensively for social bonding, anxiety reduction, trust behavior, and sexual health — earning it the nickname "the love hormone." The FDA approved synthetic oxytocin (Pitocin) decades ago for labor induction and postpartum hemorrhage control. All behavioral and psychiatric applications — social anxiety, autism spectrum support, PTSD, sexual dysfunction — remain investigational. A 2005 study by Kosfeld et al. in Nature showed intranasal oxytocin significantly increased trust in a financial game, sparking a wave of behavioral research. Plasma half-life is extremely short at roughly 3 minutes IV, but central effects after intranasal dosing persist for 2-4 hours. Bioavailability is low (under 2% systemically), yet brain concentrations reach meaningful levels through nasal administration. Doses in clinical trials typically range from 20-40 IU with no serious adverse effects in short-term studies.